Weill Cornell Medicine and Weill Bugando School of Medicine collaborate to strengthen medical education, health care and innovative global health research at both institutions.
Pregnant women who had a previous COVID-19 infection and received full vaccination and a booster have the strongest immune protection from the disease – and pass that protection along to their unborn babies, according to a new study.
An agricultural economist, a theoretical physicist, a plant biologist and a physiologist have each been elected to the National Academy of Sciences, the academy announced May 3.
Many medical studies record a patient’s race using only the broad categories from the U.S. Census, which may conceal racial health disparities, a new Cornell-led study reports.
A team of researchers has discovered a non-invasive biomarker that could aid with earlier diagnosis of breast cancer, the most common cancer among women, which will likely affect one in 13 women during their lives.
A new study investigated whether the structure of the 340B Drug Pricing Program inhibits the use of biosimilar medications, which are medically equivalent but not identical to original biologic drugs due to production differences.
A novel combination of artificial intelligence and production techniques could change the future of nanomedicine, according to Cornell researchers using a new $3 million grant from the National Science Foundation to revolutionize how polymer nanoparticles are manufactured.
Twenty seniors in the Milstein Program in Technology & Humanity will graduate this year with degrees in everything from biology to linguistics to computer science to physics.